Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs
Abstract
Share and Cite
Figueiredo, C.S.; Roseira, E.S.; Viana, T.T.; Silveira, M.A.D.; de Melo, R.M.V.; Fernandez, M.G.; Lemos, L.M.G.; Passos, L.C.S. Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs. Pharmaceuticals 2023, 16, 1242. https://doi.org/10.3390/ph16091242
Figueiredo CS, Roseira ES, Viana TT, Silveira MAD, de Melo RMV, Fernandez MG, Lemos LMG, Passos LCS. Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs. Pharmaceuticals. 2023; 16(9):1242. https://doi.org/10.3390/ph16091242
Chicago/Turabian StyleFigueiredo, Clara Salles, Elias Soares Roseira, Tainá Teixeira Viana, Marcelo Augusto Duarte Silveira, Rodrigo Morel Vieira de Melo, Miguel Godeiro Fernandez, Livia Maria Goes Lemos, and Luiz Carlos Santana Passos. 2023. "Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs" Pharmaceuticals 16, no. 9: 1242. https://doi.org/10.3390/ph16091242
APA StyleFigueiredo, C. S., Roseira, E. S., Viana, T. T., Silveira, M. A. D., de Melo, R. M. V., Fernandez, M. G., Lemos, L. M. G., & Passos, L. C. S. (2023). Inflammation in Coronary Atherosclerosis: Insights into Pathogenesis and Therapeutic Potential of Anti-Inflammatory Drugs. Pharmaceuticals, 16(9), 1242. https://doi.org/10.3390/ph16091242